TRCT
ASTX

Tower Research Capital (TRC)’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-15,942
Closed -$136K – 5447
2013
Q3 		$136K Buy
+15,942
New +$101K 0.01% 1040

Tower Research Capital (TRC)'s ASTX Position: Q4 2013 in Review

Tower Research Capital (TRC) sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 15,942 shares — an estimated $136K sold.

Tower Research Capital (TRC) first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $136K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Tower Research Capital (TRC) reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 15,942 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $136K.
  • Tower Research Capital (TRC) first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s ASTEX PHARMACEUTICALS, INC COM position peaked at $136K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2013, filed 31 Jan 2014.